Detalhe da pesquisa
1.
Cpd-A1 alleviates acute kidney injury by inhibiting ferroptosis.
Acta Pharmacol Sin
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641746
2.
Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.
Br J Pharmacol
; 180(20): 2641-2660, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248964
3.
N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation.
Int J Biol Macromol
; 248: 125811, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467831
4.
Targeted inhibition of TGF-ß type I receptor by AZ12601011 protects against kidney fibrosis.
Eur J Pharmacol
; 929: 175116, 2022 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780825
5.
miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-ß.
Int Immunopharmacol
; 110: 109034, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834952
6.
RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.
Int Immunopharmacol
; 112: 109262, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166972